Genmab and AbbVie Announce Broad Oncology Collaboration

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. ZETA
9. DAL
10. TMUS

Go back to Genmab and AbbVie Announce Broad Oncology Collaboration

Genmab A/S (GMAB) PT Raised to $39 at SunTrust; 'AbbVie Deal Favorably on Several Counts'

June 10, 2020 1:16 PM EDT

SunTrust analyst Asthika Goonewardene raised the price target on Genmab A/S (NASDAQ: GMAB) to $39.00 (from $36.00) while maintaining a Buy rating.

The analyst commented, "We view GMAB's deal with AbbVie (ABBV, NR) favorably on several counts. We think: (1) it puts a strong commercial partner in... More